An advanced protective suit for healthcare workers who treat Ebola patients, devised by a Johns Hopkins team, has been selected as a winning design in a global competition aimed at quickly getting new tools into the field to combat this deadly disease.
ATCC, the premier global biological materials resource and standards organization, and LGC, a leading global producer and distributor of reference materials and proficiency testing (PT) programs, announce a new agreement to provide high-quality proficiency testing programs supporting the food, beverage, animal feed, and pharmaceutical quality control markets in the United States.
San Diego-based BioMed Realty Trust Inc. has sold a 289,900-square-foot bio-manufacturing facility at 9911 Belward Campus Drive for $322.5 million to private equity firm GI Partners.
The selling price translates into a whopping $1,112 per square foot.
Johns Hopkins University’s Applied Physics Laboratory says it has experienced record growth for initiatives to move its scientific discoveries into the commercial sector in 2014.
Healthcare giant McKesson Corp. plans an aggressive move into venture capital funding for healthcare technology, expecting to commit several hundred million dollars to the effort over the next five to eight years, and hiring long-time venture capitalist Tom Rodgers as managing director of strategic venture capital operations.
University System of Maryland Chancellor William E. Kirwan, who announced in the spring his plans to step down, said this week that he will likely remain in his post at least through February as the search continues for his successor.
As an offshoot of PatentStat, I’ve assembled a set of graphs of patent inventor locations, focusing in 33 industry sectors.
Bedsores, diabetic ulcers and other chronic wounds cost the U.S. health care system $30 billion a year. Why? At least in part because the primary tool doctors and nurses use to track wounds is a basic ruler.
A ruler can measure the size of a wound, but does little to track other important qualities, such as changes in shape and tissue color. Consider that patients are usually cared for by a rotating team of nurses, who may each interpret a wound’s appearance differently, and it’s easier to see how so much money is spent tending to preventable (or at least treatable) conditions.
Recent efforts between the University of Maryland (UMD) and Bethesda-based Weinberg Medical Physics LLC (WMP) have led to a new technique to magnetically deliver drug-carrying particles to hard-to-reach targets. The method has the potential to transform the way deep-tissue tumors and other diseases are treated.
Pieris AG announced today the initiation of a Phase I clinical trial with PRS-080, an anti-hepcidin Anticalin® therapeutic protein designed to treat anemia. The trial is a placebo-controlled, single ascending dose evaluation of the compound’s safety and tolerability in healthy volunteers. Conducted in Germany, the trial is underway and patients from the first cohort have been dosed.
